Amneal Pharmaceuticals (AMRX) Net Margin Growth (3y) (2021 - 2026)
Amneal Pharmaceuticals (AMRX) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 675.00 |
| Mar 31, 2026 | 1,204.00 |
| Dec 31, 2025 | 581.00 |
| Sep 30, 2025 | 280.00 |
| Jun 30, 2025 | 2,651.00 |
| Mar 31, 2025 | 397.00 |
| Dec 31, 2024 | -165.00 |
| Sep 30, 2024 | 248.00 |
| Jun 30, 2024 | -32.00 |
| Mar 31, 2024 | -1,375.00 |
| Dec 31, 2023 | -1,625.00 |
| Sep 30, 2023 | 329.00 |
| Jun 30, 2023 | 457.00 |
| Mar 31, 2023 | -2,433.00 |
| Dec 31, 2022 | 836.00 |
| Sep 30, 2022 | 6,956.00 |
| Jun 30, 2022 | -1,742.00 |
| Mar 31, 2022 | 1,030.00 |
| Dec 31, 2021 | 57.00 |
| Sep 30, 2021 | -226.00 |